Market Cap

NutraLife Biosciences, Inc. Market Capitalization:

$35,324

USD as of Jan. 1, 2024

NutraLife Biosciences, Inc. Company Profile

NutraLife Biosciences, Inc. Main Stock Listing

OTC: NLBS

Market Capitalization History of NutraLife Biosciences, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic

Company	Market Cap (USD)
Zoetis Inc.	$89.09 B
MERCK Kommanditgesellschaft auf Aktien	$67.64 B
Takeda Pharmaceutical Company Limited	$47.71 B
Haleon plc	$38.90 B
PPD, Inc.	$16.58 B

Sector: Healthcare

Company	Market Cap (USD)
Lilly	$586.39 B
UnitedHealth Group	$504.47 B
Novo Nordisk	$461.52 B
Johnson & Johnson	$387.50 B
Merck	$296.51 B

Yearly evolution of NutraLife Biosciences, Inc. market cap

Date	Market Cap	YoY Change
Jan. 1, 2024	$35,324	-99.50%
Jan. 1, 2023	$7.1 M	-50.00%
Jan. 1, 2022	$14.1 M	-13.98%
Jan. 1, 2021	$16.4 M	-8.82%
Jan. 1, 2020	$18.0 M	-52.78%
Jan. 1, 2019	$38.2 M	-43.16%
Jan. 1, 2018	$67.1 M	-66.07%
Jan. 1, 2017	$197.8 M	711.59%
Jan. 1, 2016	$24.4 M	-92.89%
Jan. 1, 2015	$342.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

NutraLife Biosciences, Inc. Categories

United States Healthcare Drug Manufacturers—Specialty & Generic

United States Healthcare

United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

NutraLife Biosciences, Inc. has the following listings and related stock indices.

Stock: OTC: NLBS

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.